CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announced that U.S. Patent No. 12,252,713 was issued by the United States Patent and Trademark Office. The patent ...

After scoring tax abatements for a $100 million investment in The Woodlands last year, the company appears to be close to beginning the project.

John Roehrig died March 8 after a battle with ALS. During his career, he was on the front lines of the U.S. response to West Nile virus.

Giulio Cossu, MD, speaks to the lingering safety concerns related to ex vivo gene therapy in Duchenne muscular dystrophy (DMD) as long-term data are yet to be established.

The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.

Insect miRNAs can be transferred to their host plants upon feeding. This study shows that a conserved insect microRNA plays a ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

The IIT Roorkee study on Efavirenz offers a new avenue for Chikungunya treatment, bringing optimism to patients and doctors ...

Yet, the complexity of scaling viral vector processes to commercial levels and the absence of standardized approaches pose significant challenges for therapy development timelines and productivity.

Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed staff, cutting 15 workers to leave 21 still ...

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...